HER2-FGFR1 interaction induced by bispecific molecules: A novel strategy for treating breast cancer

被引：0
|
作者：
Krzyscik, Mateusz Adam
Hristova, Kalina
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-1917
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1917
引用
收藏
页数：2
相关论文
共 50 条
  • [1] FGFR1 and HER1 or HER2 co-amplification in breast cancer indicate poor prognosis
    Chen, Shinan
    Qiu, Yan
    Guo, Peng
    Pu, Tianjie
    Feng, Ye
    Bu, Hong
    ONCOLOGY LETTERS, 2018, 15 (06) : 8206 - 8214
  • [2] Novel bispecific 111In-labeled immunoconjugates (bslCs) for imaging HER2/HER3 heterodimerization in breast cancer
    Eva, Razumienko J.
    Reilly, Raymond M.
    CANCER RESEARCH, 2010, 70
  • [3] Characterization of FGFR1/2 genetic alterations reveals novel fusions of FGFR1 in Chinese breast cancer
    Wang, Y.
    Guo, L.
    Cao, L.
    Jia, M.
    Wen, L.
    Ren, C.
    Zhang, G.
    Liao, N.
    CANCER RESEARCH, 2019, 79 (04)
  • [4] A novel interaction between HER2/neu and cyclin E in breast cancer
    Mittendorf, E. A.
    Liu, Y.
    Tucker, S. L.
    McKenzie, T.
    Qiao, N.
    Akli, S.
    Biernacka, A.
    Liu, Y.
    Meijer, L.
    Keyomarsi, K.
    Hunt, K. K.
    ONCOGENE, 2010, 29 (27) : 3896 - 3907
  • [5] A novel interaction between HER2/neu and cyclin E in breast cancer
    E A Mittendorf
    Y Liu
    S L Tucker
    T McKenzie
    N Qiao
    S Akli
    A Biernacka
    Y Liu
    L Meijer
    K Keyomarsi
    K K Hunt
    Oncogene, 2010, 29 : 3896 - 3907
  • [6] FGFR1 Amplification and Response to Neoadjuvant Anti-HER2 Treatment in Early HER2-Positive Breast Cancer
    Gaibar, Maria
    Novillo, Apolonia
    Romero-Lorca, Alicia
    Malon, Diego
    Anton, Beatriz
    Moreno, Amalia
    Fernandez-Santander, Ana
    PHARMACEUTICS, 2022, 14 (02)
  • [7] A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
    Zong, Hui-fang
    Li, Xi
    Han, Lei
    Wang, Lei
    Liu, Jun-jun
    Yue, Ya-li
    Chen, Jie
    Ke, Yong
    Jiang, Hua
    Xie, Yue-qing
    Zhang, Bao-hong
    Zhu, Jian-wei
    ACTA PHARMACOLOGICA SINICA, 2024, 45 (08) : 1727 - 1739
  • [8] Treating the HER2 Pathway in Early and Advanced Breast Cancer
    Pegram, Mark D.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (04) : 751 - +
  • [9] Inhibitors of Bcl-3 as a Novel Therapeutic Strategy for HER2+Breast Cancer
    Soukupova, J.
    Brancale, A.
    Westwell, A.
    Clarkson, R.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S225 - S225
  • [10] Treatment strategy for HER2-positive breast cancer
    Hirofumi Mukai
    International Journal of Clinical Oncology, 2010, 15 : 335 - 340
12345